A mutation found in esophageal cancer alters integrin β4 mRNA splicing
Article
Kelly, GT, Faraj, R, Dai, Z et al. (2020). A mutation found in esophageal cancer alters integrin β4 mRNA splicing
. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 529(3), 726-732. 10.1016/j.bbrc.2020.06.078
Kelly, GT, Faraj, R, Dai, Z et al. (2020). A mutation found in esophageal cancer alters integrin β4 mRNA splicing
. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 529(3), 726-732. 10.1016/j.bbrc.2020.06.078
Integrin β4 (CD104, mRNA: ITGβ4) contributes to anchoring cells to the extracellular matrix and is regulated in many cancer types where it contributes to tumor progression. One splice variant, integrin β4E, is poorly characterized. We extracted several mutations from tumor samples within ITGB4 near the splice site that controls ITGβ4E production, and computational analysis predicted six of these would alter splicing to alter ITGβ4E abundance. One of these mutations, from an esophageal squamous cell carcinoma sample, was predicted to increase splicing toward ITGβ4E. We verified this effect using a minigene, and observed that integrin β4E slows esophageal squamous cell migration while other variants enhance migration, demonstrating that integrin β4E regulation through mutations may contribute to esophageal squamous cell tumorigenesis.
